Since joining last summer, Sapna Patel, MD, has revitalized melanoma clinical trials at the CU Cancer Center, with seven new studies launching soon. Her work spans rare eye melanomas and cutting-edge immunotherapies, positioning the center as a key hub for melanoma care and research.